Cryopreservation of Sperm: A Review.

Sperm cryopreservation has been used as a sperm preservation solution for infertility issues faced by men undergoing cancer treatment for over 40 years. Recent developments in sperm cryopreservation and its wide variety of therapeutic uses are discussed in this article, which offers a succinct and up-to-date overview of the relevant literature. Recently, sperm cryopreservation has been employed for a wider variety of therapeutic purposes. As a result, sperm freezing is becoming available to a wider variety of patients, which requires more specialized personnel and increases overhead expenses. While sperm cryopreservation before cancer treatment is accessible in many countries, oncology doctors' referral rates and patient participation with cryopreservation services have been observed to be poor. In addition, there are still moral concerns with sperm banking, including whether or not donors' identities should be protected and whether or not a deceased person's sperm should be used after his or her death. This article discusses the recent developments in sperm cryopreservation technology and the moral questions that have arisen around this practice, with an eye toward how a deeper knowledge of these concerns can help more people get access to treatments that might help preserve their fertility. A sperm bank will notify clients about the screenings it does and the background information it gathers on individual donors to guarantee the safety and quality of the sperm they get. The viability and quantity of viable sperm in a thawed sample are often guaranteed by a sperm bank. They will look for very fertile males who can donate sperm that can withstand the freezing and thawing procedure. In many cases, sperm banks advertise their samples as having a certain number of viable sperm per milliliter, and they may provide many sample types for various applications (intracytoplasmic sperm injection and intrauterine insemination).

Diagnosis of Sanfilippo disease correlating clinical, radiological and biochemical findings-a case report.

Mucopolysaccharidoses (MPS) are a group of genetic diseases and its diagnosis is a challenging task due to multiple differential diagnosis. We had combined clinical findings, radiological and ophthalmological features. Biochemical test for urine glycosaminoglycans (GAG) was done for confirmation of diagnosis in the patient. The case of Sanfilippo disease was characterized by slowly progressive, severe CNS involvement with mild somatic disease. Radiological features were suggestive of Sanfilippo disease and urine GAG test for MPS was positive in the case. With the clinical features we had multiple differential diagnoses. The radiological investigations minimized the list and the biochemical test confirmed GAG in urine. In this case the combination of clinical, radiological and biochemical findings confirmed the diagnosis of Sanfilippo disease.